{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:32:48Z","timestamp":1786116768910,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005329","name":"Guizhou Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["Qian Ke He Ji Chu-ZK[2024] Zhong Dian 029"],"award-info":[{"award-number":["Qian Ke He Ji Chu-ZK[2024] Zhong Dian 029"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bmcl.2026.130729","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:53:53Z","timestamp":1783353233000},"page":"130729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis and biological investigation of phenothiazine-based derivatives as potential HDAC6 inhibitors for treatment of glioblastoma multiforme"],"prefix":"10.1016","volume":"140","author":[{"given":"Ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longjia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130729_bb0005","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s11427-024-2810-y","article-title":"Lifetime probabilities of developing and dying from cancer in China: comparison with Japan and the United States in 2022","volume":"68","author":"Zhu","year":"2025","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.bmcl.2026.130729_bb0010","doi-asserted-by":"crossref","first-page":"e2440381","DOI":"10.1001\/jamanetworkopen.2024.40381","article-title":"Trends in cancer incidence and potential associated factors in China","volume":"7","author":"Li","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.bmcl.2026.130729_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1347877","article-title":"Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features","volume":"15","author":"Ballest\u00edn","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmcl.2026.130729_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.944452","article-title":"Advances in immunotherapy for glioblastoma multiforme","volume":"13","author":"Mahmoud","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmcl.2026.130729_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102412","article-title":"Epidemiology of glioblastoma multiforme-literature review","volume":"14","author":"Grochans","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bmcl.2026.130729_bb0030","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","article-title":"Immunotherapy for glioblastoma: current state, challenges, and future perspectives","volume":"21","author":"Liu","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.bmcl.2026.130729_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11864-019-0619-4","article-title":"Current state of immunotherapy for treatment of glioblastoma","volume":"20","author":"Mcgranahan","year":"2019","journal-title":"Curr Treat Options in Oncol"},{"key":"10.1016\/j.bmcl.2026.130729_bb0040","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in Cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bmcl.2026.130729_bb0045","article-title":"Mechanisms of HDACs in cancer development","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmcl.2026.130729_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104544","article-title":"Choosing pan-HDAC or selective HDAC inhibitors for anticancer therapy","volume":"30","author":"Ganai","year":"2025","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmcl.2026.130729_bb0055","doi-asserted-by":"crossref","first-page":"16313","DOI":"10.1021\/acs.jmedchem.2c01132","article-title":"Development of alkylated hydrazides as highly potent and selective class I histone deacetylase inhibitors with T cell modulatory properties","volume":"65","author":"Sun","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115800","article-title":"Technologies of targeting histone deacetylase in drug discovery: current progress and emerging prospects","volume":"261","author":"Ru","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0065","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3390\/cells14241997","article-title":"Next-generation HDAC inhibitors: advancing zinc-binding Group Design for Enhanced Cancer Therapy","volume":"14","author":"Hawash","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bmcl.2026.130729_bb0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/acsmedchemlett.4c00494","article-title":"Carboxamide-bearing Panobinostat analogues designed to interact with E103-D104 at the cavity opening of class I HDAC isoforms","volume":"16","author":"Rosser","year":"2025","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130729_bb0075","doi-asserted-by":"crossref","first-page":"18216","DOI":"10.1021\/acs.jmedchem.5c00479","article-title":"Improved pharmacokinetic profiles of HDAC6 inhibitors via cap group modifications","volume":"68","author":"Olaoye","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1021\/acsmedchemlett.5c00500","article-title":"First-in-class potent, dual HDAC6\/proteasome inhibitors lacking a hydroxamic acid motif: discovery of novel anti-multiple myeloma agents","volume":"17","author":"Chan","year":"2026","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130729_bb0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/cells10010012","article-title":"HDAC6 in diseases of cognition and of neurons","volume":"10","author":"Lopresti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bmcl.2026.130729_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116634","article-title":"Biological function and small molecule inhibitors of histone deacetylase 11","volume":"276","author":"Jia","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1653588","article-title":"The regulatory mechanisms and treatment of HDAC6 in immune dysregulation diseases","volume":"16","author":"Liang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmcl.2026.130729_bb0100","doi-asserted-by":"crossref","first-page":"10080","DOI":"10.1021\/acs.jmedchem.3c00977","article-title":"Discovery of the first irreversible HDAC6 isoform selective inhibitor with potent anti-multiple myeloma activity","volume":"66","author":"Liu","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116676","article-title":"Biological and structural investigation of tetrahydro-\u03b2-carboline-based selective HDAC6 inhibitors with improved stability","volume":"276","author":"Scheuerer","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0110","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1021\/acs.jmedchem.4c03231","article-title":"Structural optimization of 1, 3-Diaryl-1, 2, 4-triazole-capped histone deacetylase 6 inhibitors to obtain novel antiesophageal cancer candidates","volume":"68","author":"Zhang","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0115","doi-asserted-by":"crossref","first-page":"10122","DOI":"10.1021\/acs.jmedchem.5c03139","article-title":"GV-001, an Oral available histone deacetylase 6 inhibitor for the treatment of autosomal dominant polycystic kidney disease","volume":"69","author":"Wu","year":"2026","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11427-024-2616-7","article-title":"FSD1 inhibits glioblastoma diffuse infiltration through restriction of HDAC6-mediated microtubule deacetylation","volume":"68","author":"Xiao","year":"2025","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.bmcl.2026.130729_bb0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2017.12.005","article-title":"HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH\/Gli1 signaling pathway","volume":"415","author":"Yang","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmcl.2026.130729_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118373","article-title":"Second generation repurposing of phenothiazine antipsychotic drugs as antifungal lead molecules via optimization of phenoxazine derivatives","volume":"302","author":"Guin","year":"2026","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jhet.70115","article-title":"A concise review of phenothiazine based antipsychotic drugs and their syntheses","volume":"63","author":"Bandishti","year":"2026","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2025.137910","article-title":"A novel ratiometric electrochemical sensor based on bifunctional copper-coordinated polydopamine molecular imprinting for the detection of chlorpromazine","volume":"440","author":"Yuan","year":"2025","journal-title":"Sens Actuators B Chem"},{"key":"10.1016\/j.bmcl.2026.130729_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2025.115292","article-title":"Redox-driven fluorescent sensing platform for perphenazine detection using 4-aminothiophenol and polyvinylpyrrolidone-stabilized silver nanoclusters","volume":"218","author":"Alaseem","year":"2025","journal-title":"Microchem J"},{"key":"10.1016\/j.bmcl.2026.130729_bb0150","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.tips.2025.03.005","article-title":"Repurposing trifluoperazine for glioblastoma treatment","volume":"46","author":"De Silva","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmcl.2026.130729_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2025.102510","article-title":"Mitochondria and cell death signalling","volume":"94","author":"Hall-Younger","year":"2025","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bmcl.2026.130729_bb0160","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bbamcr.2015.12.021","article-title":"Cellular functions of programmed cell death 5","volume":"1863","author":"Li","year":"2016","journal-title":"Biochim Biophys Acta, Mol Cell Res"},{"key":"10.1016\/j.bmcl.2026.130729_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114599","article-title":"Mechanistic correlation between mitochondrial permeability transition pores and mitochondrial ATP dependent potassium channels in ischemia reperfusion","volume":"162","author":"Behera","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2026.130729_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1816","article-title":"Cyclin-dependent kinases: masters of the eukaryotic universe","volume":"15","author":"Pluta","year":"2024","journal-title":"WIREs RNA"},{"key":"10.1016\/j.bmcl.2026.130729_bb0175","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1007\/s11030-024-11052-y","article-title":"Design, synthesis and antitumor activity of 4-indazolylpyrimidine derivatives as EGFR inhibitors","volume":"29","author":"Yang","year":"2025","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmcl.2026.130729_bb0180","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmcl.2026.130729_bb0185","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1021\/acs.jctc.5c00677","article-title":"Force field-driven Backmapping for multiscale molecular dynamics","volume":"21","author":"Guo","year":"2025","journal-title":"J Chem Theory Comput"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:40:01Z","timestamp":1786020001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26001964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"alternative-id":["S0960894X26001964"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130729","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological investigation of phenothiazine-based derivatives as potential HDAC6 inhibitors for treatment of glioblastoma multiforme","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130729"}}